Antimicrobials and antiseptics: Lowering effect on ocular surface bacterial flora – A systematic review

IF 3 3区 医学 Q1 OPHTHALMOLOGY
Mariantonia Ferrara, Francesca Gatti, David Lockington, Antonio Iaria, Stephen Kaye, Gianni Virgili, Pasquale Aragona, Francesco Semeraro, Vito Romano
{"title":"Antimicrobials and antiseptics: Lowering effect on ocular surface bacterial flora – A systematic review","authors":"Mariantonia Ferrara,&nbsp;Francesca Gatti,&nbsp;David Lockington,&nbsp;Antonio Iaria,&nbsp;Stephen Kaye,&nbsp;Gianni Virgili,&nbsp;Pasquale Aragona,&nbsp;Francesco Semeraro,&nbsp;Vito Romano","doi":"10.1111/aos.15732","DOIUrl":null,"url":null,"abstract":"<p>Topical antimicrobials and antiseptics are used perioperatively to reduce the ocular surface bacteria flora (OSBF) that are involved in the development of post-operative infectious complications. However, their effectiveness is still a controversial topic. This systematic review, performed according to the PRISMA guidelines and registered in PROSPERO, aims to provide an overview of the efficacy of the agents currently used in peri-cataract surgery and -intravitreal injections (IVI) in lowering the OSBF. Although effective in lowering OSBF, perioperative topical antimicrobials are associated with the risk of resistance development, with no obvious additional benefit compared with topical antisepsis. Conversely, the effectiveness of topical antiseptics before cataract surgery and IVI is strongly supported. Based on the available evidence, perioperative antimicrobials are not recommended, whereas the perioperative use of antiseptics is strongly recommended as prophylactic treatment for lowering the infection due to OSBF. Post-operative antimicrobials may be considered in eyes at higher risk for infection.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":"102 3","pages":"e215-e228"},"PeriodicalIF":3.0000,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/aos.15732","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/aos.15732","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Topical antimicrobials and antiseptics are used perioperatively to reduce the ocular surface bacteria flora (OSBF) that are involved in the development of post-operative infectious complications. However, their effectiveness is still a controversial topic. This systematic review, performed according to the PRISMA guidelines and registered in PROSPERO, aims to provide an overview of the efficacy of the agents currently used in peri-cataract surgery and -intravitreal injections (IVI) in lowering the OSBF. Although effective in lowering OSBF, perioperative topical antimicrobials are associated with the risk of resistance development, with no obvious additional benefit compared with topical antisepsis. Conversely, the effectiveness of topical antiseptics before cataract surgery and IVI is strongly supported. Based on the available evidence, perioperative antimicrobials are not recommended, whereas the perioperative use of antiseptics is strongly recommended as prophylactic treatment for lowering the infection due to OSBF. Post-operative antimicrobials may be considered in eyes at higher risk for infection.

Abstract Image

抗菌剂和防腐剂:降低对眼表细菌菌群的影响--系统综述
围手术期使用局部抗菌剂和防腐剂是为了减少眼表细菌菌群(OSBF),而眼表细菌菌群与术后感染并发症的发生有关。然而,它们的有效性仍是一个有争议的话题。本系统性综述根据 PRISMA 指南进行,并在 PROSPERO 上进行了注册,旨在概述目前用于白内障围手术和玻璃体内注射(IVI)的药物在降低 OSBF 方面的疗效。围手术期局部使用抗菌药虽然能有效降低OSBF,但也有产生耐药性的风险,而且与局部抗菌相比没有明显的额外益处。相反,白内障手术和人工晶体植入术前局部使用抗菌药的有效性得到了有力的支持。根据现有证据,不建议在围手术期使用抗菌药,但强烈建议在围手术期使用抗菌药作为预防性治疗,以降低因 OSBF 引起的感染。对于感染风险较高的眼睛,可考虑术后使用抗菌药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Ophthalmologica
Acta Ophthalmologica 医学-眼科学
CiteScore
7.60
自引率
5.90%
发文量
433
审稿时长
6 months
期刊介绍: Acta Ophthalmologica is published on behalf of the Acta Ophthalmologica Scandinavica Foundation and is the official scientific publication of the following societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER). Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信